Oramed Pharmaceuticals (ORMP) Stock Chart & Stock Price History $2.55 +0.09 (+3.66%) (As of 12:03 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Oramed Pharmaceuticals Stock Price Performance 5 Day Performance+7.59%1 Month Performance+9.91%3 Month Performance+5.81%6 Month Performance+15.38%Year-To-Date Performance+10.39%1 Year Performance+19.72% Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! ORMP Stock Chart for Tuesday, December, 3, 2024 ORMP Chart by TradingView Oramed Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/02/2024$2.37$2.47+4.01%$2.50$2.36362,586 shs$99.36 million11/29/2024$2.37$2.37$2.39$2.3549,614 shs$95.54 million11/28/2024$2.37$2.37$2.41$2.3699,362 shs$95.54 million11/27/2024$2.37$2.37$2.41$2.3699,262 shs$95.54 million11/26/2024$2.35$2.37+0.85%$2.43$2.30169,951 shs$95.54 million11/25/2024$2.34$2.35+0.43%$2.38$2.33171,057 shs$94.73 million Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/22/2024$2.31$2.34+1.30%$2.39$2.30106,953 shs$94.33 million11/21/2024$2.26$2.31+2.21%$2.36$2.27124,846 shs$93.12 million11/20/2024$2.30$2.26-1.74%$2.30$2.2660,933 shs$91.10 million11/19/2024$2.17$2.30+5.99%$2.31$2.18106,589 shs$92.71 million11/18/2024$2.23$2.17-2.69%$2.30$2.13237,810 shs$87.48 million11/15/2024$2.34$2.23-4.50%$2.33$2.22110,058 shs$89.89 million11/14/2024$2.32$2.34+0.65%$2.37$2.31104,074 shs$94.13 million11/13/2024$2.34$2.32-0.85%$2.35$2.3175,382 shs$93.52 million11/12/2024$2.32$2.34+0.86%$2.35$2.27144,244 shs$95.40 million11/11/2024$2.31$2.32+0.43%$2.42$2.30240,756 shs$94.59 million11/08/2024$2.38$2.31-2.94%$2.40$2.2776,205 shs$94.18 million11/07/2024$2.34$2.38+1.71%$2.40$2.27126,205 shs$97.03 million11/06/2024$2.35$2.34-0.43%$2.43$2.30235,813 shs$95.40 million11/05/2024$2.39$2.35-1.67%$2.37$2.3436,845 shs$95.81 million11/04/2024$2.32$2.39+3.02%$2.42$2.3292,340 shs$97.44 million Related Companies Contineum Therapeutics Stock Chart Amylyx Pharmaceuticals Stock Chart Voyager Therapeutics Stock Chart Kodiak Sciences Stock Chart Neurogene Stock Chart biote Stock Chart Cryoport Stock Chart Alvotech Stock Chart Jasper Therapeutics Stock Chart 4D Molecular Therapeutics Stock Chart Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORMP) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oramed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
